全文获取类型
收费全文 | 6869篇 |
免费 | 435篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 50篇 |
儿科学 | 107篇 |
妇产科学 | 113篇 |
基础医学 | 970篇 |
口腔科学 | 185篇 |
临床医学 | 772篇 |
内科学 | 1523篇 |
皮肤病学 | 91篇 |
神经病学 | 754篇 |
特种医学 | 258篇 |
外科学 | 1089篇 |
综合类 | 53篇 |
一般理论 | 3篇 |
预防医学 | 459篇 |
眼科学 | 117篇 |
药学 | 406篇 |
中国医学 | 7篇 |
肿瘤学 | 364篇 |
出版年
2023年 | 42篇 |
2022年 | 87篇 |
2021年 | 186篇 |
2020年 | 134篇 |
2019年 | 152篇 |
2018年 | 186篇 |
2017年 | 168篇 |
2016年 | 154篇 |
2015年 | 189篇 |
2014年 | 257篇 |
2013年 | 365篇 |
2012年 | 569篇 |
2011年 | 604篇 |
2010年 | 337篇 |
2009年 | 315篇 |
2008年 | 485篇 |
2007年 | 492篇 |
2006年 | 437篇 |
2005年 | 447篇 |
2004年 | 405篇 |
2003年 | 343篇 |
2002年 | 287篇 |
2001年 | 51篇 |
2000年 | 46篇 |
1999年 | 62篇 |
1998年 | 46篇 |
1997年 | 35篇 |
1996年 | 32篇 |
1995年 | 35篇 |
1994年 | 20篇 |
1993年 | 23篇 |
1992年 | 27篇 |
1991年 | 26篇 |
1990年 | 20篇 |
1989年 | 13篇 |
1988年 | 9篇 |
1987年 | 20篇 |
1986年 | 17篇 |
1985年 | 15篇 |
1984年 | 12篇 |
1983年 | 9篇 |
1981年 | 8篇 |
1979年 | 23篇 |
1978年 | 15篇 |
1975年 | 13篇 |
1973年 | 13篇 |
1972年 | 8篇 |
1969年 | 11篇 |
1968年 | 13篇 |
1967年 | 9篇 |
排序方式: 共有7321条查询结果,搜索用时 0 毫秒
71.
Marjolein M. N. Leeuwenburgh MD PhD Hein B. A. C. Stockmann MD PhD Wim H. Bouma MD PhD Alexander P. J. Houdijk MD PhD Matthijs F. Verhagen MD Bart Vrouenraets MD PhD Lodewijk P. J. Cobben MD PhD Patrick M. M. Bossuyt PhD Jaap Stoker MD PhD Marja A. Boermeester MD PhD the OPTIMAP Study Group 《Academic emergency medicine》2014,21(5):487-496
72.
73.
Bonnie R. Valgaeren Bart Pardon Evy Goossens Stefanie Verherstraeten Sophie Roelandt Leen Timbermont Nicky Van Der Vekens Sabrina Stuyvaert Linde Gille Laura Van Driessche Freddy Haesebrouck Richard Ducatelle Filip Van Immerseel Piet Deprez 《Toxins》2015,7(7):2586-2597
Enterotoxaemia is a disease with a high associated mortality rate, affecting beef and veal calves worldwide, caused by C. perfringens alpha toxin and perfringolysin. A longitudinal study was conducted to determine the dynamics of antibodies against these toxins in 528 calves on 4 beef and 15 veal farms. The second study aimed to determine the effect of solid feed intake on the production of antibodies against alpha toxin and perfringolysin. The control group only received milk replacer, whereas in the test group solid feed was provided. Maternal antibodies for alpha toxin were present in 45% of the veal calves and 66% of the beef calves. In beef calves a fluent transition from maternal to active immunity was observed for alpha toxin, whereas almost no veal calves developed active immunity. Perfringolysin antibodies significantly declined both in veal and beef calves. In the second study all calves were seropositive for alpha toxin throughout the experiment and solid feed intake did not alter the dynamics of alpha and perfringolysin antibodies. In conclusion, the present study showed that veal calves on a traditional milk replacer diet had significantly lower alpha toxin antibodies compared to beef calves in the risk period for enterotoxaemia, whereas no differences were noticed for perfringolysin. 相似文献
74.
75.
76.
Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven‐year follow‐up study
下载免费PDF全文
![点击此处可从《American journal of hematology》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Charlotte F. J. van Tuijn Marein Schimmel Eduard J. van Beers Erfan Nur Bart J. Biemond 《American journal of hematology》2017,92(10):E584-E590
Organ damage in sickle cell disease (SCD) is a crucial determinant for disease severity and prognosis. In a previous study, we analyzed the prevalence of SCD‐related organ damage and complications in adult sickle cell patients. We now describe a seven‐year follow‐up of this cohort.All patients from the primary analysis in 2006 (n = 104), were included for follow‐up. Patients were screened for SCD‐related organ damage and complications (microalbuminuria, renal failure, elevated tricuspid regurgitation flow velocity (TRV) (≥2.5 m/seconds), retinopathy, iron overload, cholelithiasis, avascular osteonecrosis, leg ulcers, acute chest syndrome (ACS), stroke, priapism and admissions for vaso‐occlusive crises (VOC) biannually. Upon 7 years of follow‐up, progression in the prevalence of avascular osteonecrosis (from 12.5% to 20.4%), renal failure (from 6.7% to 23.4%), retinopathy (from 39.7% to 53.8%) was observed in the whole group. In HbSS/HbSβ0‐thal patients also progression in microalbuminuria (from 34% to 45%) and elevated TRV (from 40% to 48%) was observed while hardly any progression in the prevalence of cholelithiasis, priapism, stroke or chronic ulcers was seen. The proportion of patients with at least one episode of ACS increased in the group of HbSS/HbSβ0‐thal patients from 32% to 49.1%. In conclusion, 62% of the sickle cell patients in this prospective cohort study developed a new SCD‐related complication in a comprehensive care setting within 7 years of follow‐up. Although the hospital admission rate for VOC remained stable, multiple forms of organ damage increased substantially. These observations underline the need for continued screening for organ damage in all adult patients with SCD. 相似文献
77.
78.
Paroxysmal nocturnal hemoglobinuria, aplastic anemia, and myelodysplastic syndrome are a spectrum of acquired marrow failure, having a common pathologic thread of both immune dysregulation and the development of abnormal hematopoiesis. Allogeneic hematopoietic cell transplantation plays a critical role in the treatment of these disorders and, for many patients, is the only treatment modality with demonstrated curative potential. In recent years, there have been many breakthroughs in the understanding of the pathogenesis of these uncommon disorders. The subsequent advances in non-transplant therapies, along with concurrent improvement in outcomes after hematopoietic cell transplantation, necessitate continual appraisal of the indications, timing, and approaches to transplantation for acquired marrow failure syndromes. We review here contemporary and critical new findings driving current treatment decisions. 相似文献
79.
Combined anticoagulant and antiselectin treatments prevent lethal intravascular coagulation
下载免费PDF全文
![点击此处可从《Blood》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Norman KE Cotter MJ Stewart JB Abbitt KB Ali M Wagner BE Wallace WA Forlow SB Hellewell PG 《Blood》2003,101(3):921-928
Widespread microvascular injury followed by vessel obstruction may lead to disseminated intravascular coagulation (DIC). We describe a murine model wherein leukocytes interacting with inflamed microvessels in vivo are activated by antibodies. Treatment of tumor necrosis factor alpha (TNF-alpha)-primed mice with anti-Ly-6G antibodies reproduced many of the features of septic or traumatic shock including microvessel obstruction and coagulation, severe vasculitis, respiratory difficulties, and vascular leakage. Mice lacking either E-selectin or P-selectin were protected from this reaction as were animals treated with a combination of either selectin-blocking antibodies and heparin or a selectin antagonist plus heparin. Combined blockade of leukocyte/platelet adhesion and coagulation may provide convincing protection in DIC. 相似文献
80.
van Pinxteren B Numans ME Lau J de Wit NJ Hungin AP Bonis PA 《Journal of general internal medicine》2003,18(9):755-763
OBJECTIVE: To investigate the efficacy of acid suppressant drugs in the empirical treatment of gastroesophageal reflux disease (GERD) and in the treatment of endoscopy-negative reflux disease (ENRD). DESIGN: medline, embase, and the Cochrane Controlled Trials Register were searched. Bibliographies were reviewed. SETTING: Studies were eligible that compared the short-term use of proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs) with each other or with placebo in adults with GERD who were enrolled irrespective of endoscopic findings (empirical cases) or in whom endoscopy showed no signs of esophagitis (endoscopy-negative cases). MEASUREMENTS: Of 1,408 studies, only 13 could be included for meta-analysis. Data on 3,433 patients empirically treated for GERD and 2,520 patients treated for ENRD were extracted. The primary endpoint was relief of heartburn. MAIN RESULTS: In the empirical treatment of GERD, the summary relative risk (sRR) for symptom relief from H2RAs versus placebo was 0.77 (95% confidence interval [95% CI], 0.60 to 0.99). RR in the only placebo-controlled PPI trial was 0.35 (95% CI, 0.26 to 0.46). The sRR for standard dose PPIs versus H2RAs was 0.55 (95% CI, 0.44 to 0.68). In treatment of ENRD, both PPIs (sRR, 0.64; 95% CI, 0.52 to 0.79) and H2RAs (sRR, 0.78; 95% CI, 0.62 to 0.97) were superior to placebo, and PPIs were superior to H2RAs (sRR, 0.81; 95% CI, 0.70 to 0.95). CONCLUSIONS: Acid suppressant therapy (with a PPI or an H2RA) is more effective than placebo for short-term relief of heartburn in patients with persistent symptoms who are treated empirically for GERD and in those in whom esophagitis was excluded after endoscopy. The benefit of PPIs compared with H2RAs is more pronounced in patients treated empirically. 相似文献